KALY Announces New HempTantation CBD Sunscreen for $17 Billion Market

Kaly1

DALLAS, May 2, 2019 /PRNewswire/ — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (‘KALY’) today announced the all new HempTantation, a hemp derived CBD infused sunscreen. KALY has a U.S. Patented cannabis extraction process. The company is conducting ongoing research and development with its cannabis extracts to develop a variety of pharmaceutical treatments for a range of health conditions…

Read More

This Pot Stock Just Made the Biggest Acquisition Ever in the U.S. Cannabis Industry

Cresco Labs (CNSX:CL) might not be a household name in the cannabis industry yet, but that might change very soon. On Monday, the company announced that it was acquiring Origin House (CNSX:OH) in what is going to be the largest transaction for a U.S. cannabis company yet — $1.1 billion. Up until now, the big acquisitions have involved Canadian cannabis companies, and…

Read More

GDET Introduces Hemp Derived CBD Products Made In The USA For $22 Billion Marketplace

GD Entertainment And Technology

FORT LEE, N.J., April 02, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — GD Entertainment And Technology (OTC: GDET) (“GDET” or the “Company”) today introduced its all new hemp derived CBD products that will be for sale under the Company’s new “The Greenery” label with an official launch date scheduled for April 20th, 2019, the annual 420 celebration day for cannabis…

Read More

KALY – Kali-Extracts Develops Cannabis Treatment For Type 2 Diabetes Expected To Be $64 Billion Market

Kaly1

DALLAS, April 02, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today unveiled its ongoing research and development of a cannabis treatment for Type 2 Diabetes. Kali-Extracts, through its patented cannabis extraction process, is developing a variety of treatments for various health issues. KALY recently published a research report on…

Read More

3 Marijuana Stocks Wall Street Thinks You Should Buy

Marijuana stocks aren’t exactly institutional investor favourites. With the vast majority of them being owned by retail traders, they’re real “small time investor” staples. That doesn’t necessarily mean that smart money is against them, though. Many of Canada’s top marijuana stocks enjoy favourable analysts’ ratings, and some of those have target prices that are far higher than their current prices.…

Read More